No Data
Wanbang Pharmaceutical: Report for the third quarter of 2024
Express News | Wanbang Pharmaceutical: Intends to repurchase shares amounting to 15 million yuan to -30 million yuan.
About 5.4068 million restricted shares of Wanbang Medicine (301520.SZ) will be listed for trading on September 25th.
Wanbang Pharmaceutical (301520.SZ) announced that the shares to be released from restriction this time were issued before the company's initial public offering...
Anhui Wanbang Pharmaceutical Technology: Half-year report for the year 2024.
Anhui Wanbang Pharmaceutical Technology: Summary of Half-Year Report in 2024.
Wanbang Pharmaceutical (301520.SZ): The net income in the first half of the year was 55.03296 million yuan, a year-on-year increase of 2.25%.
On August 22, Glonui announced its interim report for the first half of 2024. The operating income for the reporting period was 0.187 billion yuan, a year-on-year increase of 13.47%. The net income attributable to shareholders of the listed company was 55.03296 million yuan, a year-on-year increase of 2.25%. The net income attributable to shareholders of the listed company excluding non-recurring gains and losses was 41.3276 million yuan, a year-on-year decrease of 20.11%. The basic earnings per share were 0.83 yuan.
No Data
No Data